We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at ...

We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on uniQure (QURE – Research Report). The company’s shares ...

Qure (NASDAQ:QURE – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $18.05, but opened at $17.55. uniQure shares last traded at $17.73, with ...

On Wednesday, Uniqure NV (QURE) stock saw a decline, ending the day at $15.92 which represents a decrease of $-1.72 or -9.75% from the prior close of $17.64. The stock opened at $16.83 and touched a ...

LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing ...

Shares of uniQure (NASDAQ:QURE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat reports.

uniQure (QURE) announced the pricing of its underwritten public offering of 4,411,764 of its ordinary shares at a public offering price of $17.00 per share. The aggregate gross proceeds to uniQure ...

uniQure Inc. LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with ...

uniQure Inc. LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with ...

LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...